Who is sponsoring NCT05847257?

NCT05847257 is sponsored by Al-Mustansiriyah University.

What drugs are being tested in NCT05847257?

Interventions in NCT05847257: Letrozole tablets, Coenzyme Q10 table.

What condition does NCT05847257 study?

NCT05847257 studies Male Reproductive Problem, Infertility, Male.

Is NCT05847257 still recruiting?

NCT05847257 is currently completed. Last updated 19 February 2025.

Last reviewed 2025-02-19 · How we verify

NCT05847257

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Co Enzyme Q10 as Adjuvant Therapy to Letrozole on Spermiogram

Completed Phase 2 Last updated 19 February 2025

What this trial tests

Phase 2 trial testing Letrozole tablets in Male Reproductive Problem in 74 participants. Completed in 30 October 2022.

Timeline

1 December 2021

Primary endpoint
30 October 2022

30 October 2022

Quick facts

Lead sponsor	Al-Mustansiriyah University
Phase	Phase 2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	74
Start date	1 December 2021
Primary completion	30 October 2022
Estimated completion	30 October 2022
Sites	1 location across Iraq

Drugs / interventions tested

Letrozole tablets — full drug profile →
Coenzyme Q10 table

Conditions studied

Male Reproductive Problem — all drugs for Male Reproductive Problem →
Infertility, Male — all drugs for Infertility, Male →

Sponsor

Al-Mustansiriyah University

Who can join

Adults 18 to 60, male only, with Male Reproductive Problem or Infertility, Male. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Worldwide infertility affects about 15 % of reproductive-age couples. In many cases, infertility can't be treated, new treatment options with promising value were involved in the recent clinical trials.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Impact of coenzyme Q10 as an adjuvant therapy to letrozole on spermiogram results and sex hormone levels in Iraqi men with infertility; randomized open label comparative study.
Fadhil EB, Mohammed MM, Alkawaz UM. · · 2023 · cited 2× · PMID 38957201 · DOI 10.12688/f1000research.131985.3
Impact of coenzyme Q10 as an adjuvant therapy to letrozole on spermiogram results and sex hormone levels in Iraqi men with infertility; randomized open label comparative study
Fadhil EB, Mohammed ‎ MM, Alkawaz UM. · · 2024 · DOI 10.12688/f1000research.131985.3

Verify or expand the search:

Other trials of Letrozole tablets

Trials testing the same drug.

NCT06861803 — Laboratory and Ultrasound Findings and Response to Letrozole in PCOS Patients · not yet recruiting
NCT06354439 — Use of Letrozole for Ectopic Pregnancy · Phase 4 · recruiting
NCT07168837 — Letrozole and Cabergoline Versus Letrozole Alone in Ovulation Induction · NA · completed
NCT06367712 — Letrozole Alone Protocol Versus Using Letrozole and HCG Protocol · Phase 1 · completed
NCT05601700 — Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial) · Phase 3 · recruiting

Other Al-Mustansiriyah University trials

Trials by the same sponsor.

NCT07375004 — Injectable PRF in Non-Surgical Periodontal Treatment · NA · active not recruiting
NCT06921434 — the Effect of Monk Fruit and Splenda on Salivary Ph and Streptococcus Mutans Count in Vivo Study · NA · not yet recruiting
NCT07182526 — Effects of Adding Quercetin or Alpha Lipoic Acid to Usual Care on Symptoms and Blood Markers in Iraqi Women With Polycys · Phase 2 · recruiting
NCT07493291 — Effectiveness and Safety of Palbociclib: Brand vs. Generic in Iraqi Stage IV Breast Cancer Patients · active not recruiting
NCT07020078 — Oral Health Condition Among a Group of Ionizing Radiation Field Workers · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05847257 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Al-Mustansiriyah University
Last refreshed: 19 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05847257.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing